HORIZON trial | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

141,173 results for “HORIZON trial”

MMRF's Horizon Trial Program Enrolls First Patient to Optimize Myeloma Treatment

Amgen's Rocatinlimab Shows Promise in Eczema Trial, Myasthenia Gravis Treatment Also Succeeds

Novartis Extends Timeline for Pelacarsen Phase 3 Cardiovascular Trial to 2026

Beacon Therapeutics' AGTC-501 Shows Sustained Safety and Efficacy in X-Linked Retinitis Pigmentosa Trial

Rocatinlimab Shows Promise in Phase 3 Trial for Moderate to Severe Atopic Dermatitis

Rocatinlimab Demonstrates Significant Efficacy in Phase 3 Trials for Moderate-to-Severe Atopic Dermatitis

HIV Cure Trials at CROI 2025 Show Promise for Broader Patient Applications

ION464 Shows Promise in MSA, OnabotulinumtoxinA Explored for Essential Tremor, Dietary Challenges in Parkinson's

Lp(a)-Lowering Therapies Show Promise in Phase II Trials

Novartis' pelacarsen misses primary endpoint in Lp(a)HORIZON Phase III cardiovascular outcomes trial

Page 1 of 2346